If you’re living with moderate to severe Ulcerative Colitis (UC) and exploring new treatment options, you may be considering joining a clinical research study. Learning what to expect early on can help you feel more informed as you decide what may be right for you.
Clinical research studies, such as the EMERALD-3 UC Study, are designed to evaluate investigational study treatments while closely monitoring safety. Understanding how these studies work can help you better understand what joining may involve. Click here to learn more about the EMERALD-3 Study.
Understanding the First Step in a Clinical Research Study
Many clinical research studies include an initial step that focuses on understanding how individuals respond to an investigational study treatment over a defined period of time.
In the EMERALD-3 UC Study, this first step lasts approximately 10 weeks. During this time, researchers evaluate how adults with moderate to severe UC respond to the investigational study treatment while continuing to monitor overall health and safety.
This is carefully structured to collect important research data while providing ongoing support throughout the process.
What Happens During the First 10 Weeks?
Table of Contents
1. Screening and Baseline Appointments
Before induction begins, you’ll attend screening appointments where the study team:
- Reviews your UC history and current symptoms
- Conducts lab tests and assessments
- Confirms whether the study may be a good fit for you
If you qualify and choose to move forward, the 1st step of the study begins.
2. Receiving the Study Treatment
Study treatment options include either:
- The investigational study drug
- A placebo (an inactive treatment)
Assignment to one of these options is done randomly, which is standard in clinical research and helps ensure results are accurate and unbiased. Neither you nor the study team will know which treatment you receive during the study.
3. Regular Study Appointments
Over the 10-week period, you’ll attend scheduled clinic appointments. These appointments may include:
- Symptom check-ins
- Blood work or lab tests
- Vital signs and physical exams
- Questionnaires about how you’re feeling
- Imaging such as endoscopies
Appointment schedules are shared in advance to help with planning. Study staff aim to make appointments as efficient, clear and supportive as possible.
4. Ongoing Safety Monitoring
Your safety is a priority throughout the study. The study team closely monitors:
- Side effects or changes in health
- Symptom changes, including improvement or worsening
- Any questions or concerns you may have
You are encouraged to speak openly about how you’re feeling throughout the process.
Eligibility
You may qualify for the EMERALD-3 UC Study if you:
- Are an adult (18-80 years of age) living with Ulcerative Colitis for at least 3 months
- Have moderate to severe symptoms
- Have tried previous UC treatments that did not work well enough
- Meet additional health and safety criteria
Eligibility is confirmed through a screening process, which includes reviewing your medical history and completing required tests.
Time Commitment and Support
It’s common to have questions about how a clinical research study may fit into everyday life.
- Appointments are scheduled in advance
- You’ll receive clear instructions for each appointment
- Study staff are available to answer questions between appointments
Some studies may offer additional resources. The study team will explain what may be available.
Joining a clinical study is completely voluntary. You may ask questions at any time, take time to decide whether to move forward, and choose to leave the study if you wish.
Learning More
If you’re interested in learning more about the EMERALD-3 UC Study, click here to see whether joining a clinical research study may be an option for you. You may also talk with your healthcare provider to discuss whether clinical research could be appropriate for your situation.
